Russians race to find vaccine, but experts caution against shortcuts  FRANCE 24 EnglishView Full coverage on Google News
The country has four Covid-19 vaccines in the final stage of clinical trials.The country has four Covid-19 vaccines in the final stage of clinical trials.

China coronavirus vaccine may be ready for public in November: official - World - DAWN.COM

AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country's Department of Health told Reuters on Tuesday.AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country's Department of Health told Reuters on Tuesday.

AstraZeneca resumes COVID-19 vaccine trials in South Africa, health department says | Reuters

The company Valneva, which hopes to get approval for its Covid-19 vaccine in the second half of 2021, will supply Britain with at least 60million doses as part of the deal.The company Valneva, which hopes to get approval for its Covid-19 vaccine in the second half of 2021, will supply Britain with at least 60million doses as part of the deal.

Britain bets on another coronavirus vaccine with £1.3billion investment in Scottish factory | Daily Mail Online

Gulf News Zero Campaign aims to raise awareness to help the country flatten the curveGulf News Zero Campaign aims to raise awareness to help the country flatten the curve

COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials – Gulf News

Through aggressive promotion and selective media leaks to inflate their stock prices, pharmaceutical company executives and insiders are profiteering from the pandemic. Congress must stop them.

Pharma Insiders Are Raking in Money Despite No Guaranteed COVID-19 Vaccine | Opinion

The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.

In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval - WSJ

The studies were paused for less than a week.The studies were paused for less than a week.

AstraZeneca Resumes U.K. Clinical Trials of Its Coronavirus Vaccine After a Safety Pause | The Motley Fool

Trials of AstraZeneca Covid-19 vaccine remain on hold until midweekTrials of AstraZeneca Covid-19 vaccine remain on hold until midweek

Coronavirus: Global infections approach 30 million

50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...

Russian Direct Investment Fund CEO Stresses Tech Based on Monkey Adenoviral Vectors 'Yet Unproven' - Sputnik International

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Experts call the global response to the COVID-19 pandemic a "collective failure."Experts call the global response to the COVID-19 pandemic a "collective failure."

Pandemic total passes 29 million as cases hit daily high | CIDRAP

Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.

AstraZeneca resumed its COVID-19 vaccine trials after uncovering a mysterious reaction | Popular Science

The United Arab Emirates (UAE) on Monday granted emergency approval for use of a coronavirus vaccine developed in China, six weeks after human trials on the vaccine started in the country.

UAE approves urgent use of China-developed COVID-19 vaccine after test on 31,000 volunteers - Global Times

DUBAI: The UAE on Monday granted emergency approval for health workers to use a COVID-19 vaccine currently in its third phase of testing. Health minister Abdulrahman Al-Owais said the vaccine would be available for “first-line-of-defense heroes, who are most at risk of catching COVID-19, protecting them from any danger that they may be exposed to due to the nature of theirDUBAI: The UAE on Monday granted emergency approval for health workers to use a COVID-19 vaccine currently in its third phase of testing. Health minister Abdulrahman Al-Owais said the vaccine would

UAE approves COVID-19 vaccine for health workers | Arab News

The vaccine trial remains on hold pending a US FDA investigation into a serious side effect in the UK - sources. The vaccine trial remains on hold pending a US FDA investigation into a serious side effect in the UK - sources.

AstraZeneca COVID-19 vaccine trial in US remains on hold | News | Al Jazeera

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates - world news - Hindustan Times

Upping the phase 3 investigational vaccine trial size to 44,000 participants will also allow for the enrollment of new populations.Upping the phase 3 investigational vaccine trial size to 44,000 participants will also allow for the enrollment of new populations.

Pfizer Phase 3 Coronavirus Vaccine Data Slated For October

The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.

COVID-19: China prioritises frontline workers, says no need to vaccinate entire population - Republic World

Two scientists break down what we know about the potential Covid-19 vaccine side effects, what we might expect, and how to deal with uncertainty.Two scientists break down what we know about the potential Covid-19 vaccine side effects, what we might expect, and how to deal with uncertainty.

Coronavirus vaccine side effects: 1,000 readers asked, scientists answered

A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.

Fifteen scientists launch critique of Russia’s COVID-19 vaccine data – EURACTIV.com

The suspension of a leading coronavirus vaccine trial had dashed investors' hopes of economic recovery worldwide, but the trial will now continue.The suspension of a leading coronavirus vaccine trial had dashed investors' hopes of economic recovery worldwide, but the trial will now continue.

Stocks rise as AstraZeneca resumes vaccine trial

Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Coronavirus (Covid-19) Cases & deaths, Vaccine Latest News Update:Global Coronavirus Updates: Globally, at least 926,716 people have died after testing positive and 19.82 lakh people have recovered as well.

Global Coronavirus Latest Update, Sept 15: Covid-19 cases & deaths | Covid-19 Vaccine Latest News | Coronavirus Today News Update

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been releasedUK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency - Scientific American

AstraZeneca Plc’s Covid-19 vaccine trial remains on hold in the U.S. as regulators examine a serious side effect suffered by a U.K. patient, Reuters reported on Monday.

AstraZeneca trial on hold pending U.S. scrutiny, Reuters reports - BNN Bloomberg

Bloomberg - Are you a robot?

The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. 

Valneva signs $1.6B supply, development agreement with U.K. for coronavirus vaccine hopeful | FiercePharma

403 Forbidden

404 Not Found

A round-up of major developments related to Covid-19 across the country.A round-up of major developments related to Covid-19 across the country.

Coronavirus news bulletin: UAE approves 'emergency' use of Covid vaccine; man wakes up from 2-month coma; 4 arrested for parties - News | Khaleej Times

Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use. Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use.Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use.

Researchers highlight ‘questionable’ data in Russian coronavirus vaccine trial results

A majority of Americans in the new NBC News|SurveyMonkey poll say they don't trust what President Donald Trump has said about a coronavirus vaccine. The share of people who say they would get a government-approved vaccine for Covid-19 has decreased in recent weeks in the NBC News|SurveyMonkey Weekly Tracking poll.

Poll: Majority of adults don't trust Trump's comments on Covid-19 vaccine

In March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signedIn March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signed up to be the first volunteers to receive jab…

Debate rages over China's Covid-19 vaccines - Asia Times

China's COVID-19 vaccine could be ready for public in November: expert - CGTN

An estimated 12 million people - nearly a fifth of the population - may have contracted coronavirus, the health ministry says. An estimated 12 million people - nearly a fifth of the population - may have contracted coronavirus, the health ministry says.

Mkhize: About 12 million people in SA may have contracted Covid-19 | News24

Oxford University said that trials of a COVID-19 vaccine it is developing with AstraZeneca would resume. From the vaccine, Hungary reserved 5 million doses.Oxford University said that trials of a COVID-19 vaccine it is developing with AstraZeneca would resume. From the vaccine, Hungary reserved 5 million doses.

Coronavirus: Oxford University to Continue Testing of Vaccine Hungary Reserved

'It will be very soon. The progress is currently very smooth,' said a Chinese official.'It will be very soon. The progress is currently very smooth,' said a Chinese official.

Coronavirus vaccine in China could be ready by November say officials - Business Insider

The announcement was made on MondayThe announcement was made on Monday

UAE approves COVID-19 vaccine for front-line workers | Government – Gulf News

NHK has learned that British pharmaceutical giant AstraZeneca plans to resume clinical trials of a coronavirus vaccine in Japan soon, following their resumption in Britain.NHK has learned that British pharmaceutical giant AstraZeneca plans to resume clinical trials of a coronavirus vaccine in Japan soon, following their resumption in Britain.

AstraZeneca to resume vaccine trials in Japan | NHK WORLD-JAPAN News

Brazil's health regulator Anvisa on Tuesday authorized AstraZeneca PLC to test its COVID19 vaccine on an additional 5,000 volunteers in the country for clinical Phase III trials, the Sao Paulo university coordinating the test said.Brazil's health regulator Anvisa on Tuesday authorized AstraZeneca PLC to test its COVID19 vaccine on an additional 5,000 volunteers in the country for clinical Phase III trials, the Sao Paulo university coordinating the test said.

Brazil Authorizes Additional 5,000 Volunteers For AstraZeneca COVID-19 Vaccine